Ipca and Cadila Healthcare gear up to make drug for coronavirus
Hydroxychloroquine,
a drug whose largest manufacturer is an Indian firm, has shot into the
limelight after the US president advocated it as potential therapy for COVID-19.
Ipca
is the biggest producer of the drug. Cadila Healthcare, based in Ahmedabad, too
is a major player. Both are gearing up to meet the demand and have said there
will be enough supplies.
On
top of this, a combination hydroxychloroquine and azithromycin, a common
antibiotic, is being considered.
Vadodara-based
drug major Alembic is the domestic market leader with its brand Azithral, with
an almost 30 per cent share.
Sources
said the country’s apex health research body, the Indian Council of Medical
Research (ICMR), had included the drug in its protocol for treating COVID-19.
The ICMR, however, has not confirmed this.
Pankaj
Patel, chairman of Cadila Healthcare, said the firm was producing 20 tonnes of
Hydroxychloroquine per month, and had started ramping up production.
Read Complete Article 
Awesome article, it was exceptionally helpful! I simply began in this and I'm becoming more acquainted with it better! Cheers, keep doing awesome! Corona alcohol abuse treatment
ReplyDeletecalifornia drug rehabilitation I would like to say that this blog really convinced me to do it! Thanks, very good post.
ReplyDelete